{"id":"https://openalex.org/W4292242012","doi":"https://doi.org/10.1038/s41591-022-01936-7","title":"Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial","display_name":"Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial","alternate_titles":[],"publication_year":2022,"publication_date":"2022-08-01","ids":{"openalex":"https://openalex.org/W4292242012","doi":"https://doi.org/10.1038/s41591-022-01936-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/35953719"},"language":"en","primary_location":{"id":"doi:10.1038/s41591-022-01936-7","doi":"https://doi.org/10.1038/s41591-022-01936-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41591-022-01936-7","pdf_url":"https://www.nature.com/articles/s41591-022-01936-7.pdf","source":{"id":"https://openalex.org/S203256638","display_name":"Nature Medicine","issn_l":"1078-8956","issn":["1078-8956","1546-170X","1744-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4292242012"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nature.com/articles/s41591-022-01936-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055849986","display_name":"Stephen James Nicholls","orcid":"https://orcid.org/0000-0002-9668-4368","observed_orcids":["https://orcid.org/0000-0002-9668-4368"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephen J. Nicholls","raw_affiliation_strings":["Victorian Heart Institute, Monash University, Clayton, Victoria, Australia. Stephen.Nicholls@monash.edu","Victorian Heart Institute, Monash University, Clayton, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Victorian Heart Institute, Monash University, Clayton, Victoria, Australia. Stephen.Nicholls@monash.edu","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Victorian Heart Institute, Monash University, Clayton, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079365240","display_name":"Marc Ditmarsch","orcid":"https://orcid.org/0000-0002-2970-1893","observed_orcids":["https://orcid.org/0000-0002-2970-1893"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Ditmarsch","raw_affiliation_strings":["NewAmsterdam Pharma B.V., Naarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma B.V., Naarden, Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077848934","display_name":"John J.P. Kastelein","orcid":"https://orcid.org/0000-0003-2018-4532","observed_orcids":["https://orcid.org/0000-0003-2018-4532"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John J. Kastelein","raw_affiliation_strings":["Academic Medical Center, Amsterdam, Netherlands"],"raw_orcid":"https://orcid.org/0000-0003-2018-4532","affiliations":[{"raw_affiliation_string":"Academic Medical Center, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024129267","display_name":"Scott P. Rigby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott P. Rigby","raw_affiliation_strings":["Summit Research Group, Stow, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Summit Research Group, Stow, Ohio, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015384592","display_name":"Douglas F. Kling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Douglas Kling","raw_affiliation_strings":["NewAmsterdam Pharma B.V., Naarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma B.V., Naarden, Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068123939","display_name":"Danielle L. Curcio","orcid":"https://orcid.org/0009-0005-1672-0760","observed_orcids":["https://orcid.org/0009-0005-1672-0760"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Danielle L. Curcio","raw_affiliation_strings":["NewAmsterdam Pharma B.V., Naarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma B.V., Naarden, Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nicholas John Alp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296810283","display_name":"Medpace (United States)","ror":"https://ror.org/05mgcmd27","country_code":"US","type":"company","lineage":["https://openalex.org/I1296810283"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicholas John Alp","raw_affiliation_strings":["Medpace, Cincinnati, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medpace, Cincinnati, Ohio, USA","institution_ids":["https://openalex.org/I1296810283"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101777206","display_name":"Michael H. Davidson","orcid":"https://orcid.org/0000-0001-9342-1274","observed_orcids":["https://orcid.org/0000-0001-9342-1274"]},"institutions":[{"id":"https://openalex.org/I4405272097","display_name":"NewAmsterdam Pharma (Netherlands)","ror":"https://ror.org/03jdnwh76","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405272097"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael H. Davidson","raw_affiliation_strings":["NewAmsterdam Pharma B.V., Naarden, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewAmsterdam Pharma B.V., Naarden, Netherlands","institution_ids":["https://openalex.org/I4405272097"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5055849986"],"corresponding_institution_ids":["https://openalex.org/I56590836"],"apc_list":{"value":11390,"currency":"USD","value_usd":11390},"apc_paid":null,"fwci":23.1713,"has_fulltext":true,"cited_by_count":187,"citation_normalized_percentile":{"value":0.99768574,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"28","issue":"8","first_page":"1672","last_page":"1678"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obicetrapib","display_name":"obicetrapib","score":1.0},{"id":"https://openalex.org/keywords/cholesteryl-ester-transfer-protein-inhibitors","display_name":"cholesteryl ester transfer protein inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/high-intensity-statins","display_name":"high-intensity statins","score":0.8299999833106995},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.9380000233650208},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.875},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9580000042915344},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/high-cardiovascular-risk","display_name":"high cardiovascular risk","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C45505151","wikidata":"https://www.wikidata.org/wiki/Q424706","display_name":"Cholesterylester transfer protein","level":4,"score":0.9222742319107056},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6866573691368103},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.659420371055603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5973803400993347},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.5878349542617798},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5756791234016418},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5110381841659546},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.49861788749694824},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48490768671035767},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4690445065498352},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3963601887226105},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3522002696990967},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05765017867088318},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/s41591-022-01936-7","doi":"https://doi.org/10.1038/s41591-022-01936-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41591-022-01936-7","pdf_url":"https://www.nature.com/articles/s41591-022-01936-7.pdf","source":{"id":"https://openalex.org/S203256638","display_name":"Nature Medicine","issn_l":"1078-8956","issn":["1078-8956","1546-170X","1744-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/2eb52eb1-bb39-4977-9074-24c7c5279c0f","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/2eb52eb1-bb39-4977-9074-24c7c5279c0f","pdf_url":"https://pure.amsterdamumc.nl/ws/files/139852495/Lipid-lowering-effects-of-the-cetp-inhibitor-obicetrapib-in-combination-with-high-intensity-statins.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nicholls, S J, Ditmarsch, M, Kastelein, J J, Rigby, S P, Kling, D, Curcio, D L, Alp, N J & Davidson, M H 2022, 'Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins : a randomized phase 2 trial', Nature medicine, vol. 28, no. 8, pp. 1672-1678. https://doi.org/10.1038/s41591-022-01936-7","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:35953719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35953719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature medicine","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/d6b757e3-44f6-409d-b2ee-50f87ebf2522","doi":null,"is_oa":true,"landing_page_url":"https://pure.amc.nl/en/publications/lipid-lowering-effects-of-the-cetp-inhibitor-obicetrapib-in-combination-with-highintensity-statins(d6b757e3-44f6-409d-b2ee-50f87ebf2522).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature medicine, 28(8), 1672 - 1678. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/s41591-022-01936-7","doi":"https://doi.org/10.1038/s41591-022-01936-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41591-022-01936-7","pdf_url":"https://www.nature.com/articles/s41591-022-01936-7.pdf","source":{"id":"https://openalex.org/S203256638","display_name":"Nature Medicine","issn_l":"1078-8956","issn":["1078-8956","1546-170X","1744-7933"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4292242012.pdf","grobid_xml":"https://content.openalex.org/works/W4292242012.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1240353884","https://openalex.org/W1488193441","https://openalex.org/W1574102128","https://openalex.org/W1965398926","https://openalex.org/W2005332332","https://openalex.org/W2048760408","https://openalex.org/W2052341239","https://openalex.org/W2100595390","https://openalex.org/W2106548780","https://openalex.org/W2108169863","https://openalex.org/W2118825330","https://openalex.org/W2137621821","https://openalex.org/W2145813488","https://openalex.org/W2475308728","https://openalex.org/W2609543937","https://openalex.org/W2616536890","https://openalex.org/W2736338239","https://openalex.org/W2749237115","https://openalex.org/W2762777606","https://openalex.org/W2764023940","https://openalex.org/W2788642078","https://openalex.org/W2913429753","https://openalex.org/W2921012991","https://openalex.org/W3087544811","https://openalex.org/W3120916025","https://openalex.org/W3136636027","https://openalex.org/W3146677450","https://openalex.org/W3147144924","https://openalex.org/W3170272938","https://openalex.org/W3183857127","https://openalex.org/W3202923263","https://openalex.org/W3216396211","https://openalex.org/W4210347219","https://openalex.org/W4239553744"],"related_works":["https://openalex.org/W4379259785","https://openalex.org/W4297452823","https://openalex.org/W4293585228","https://openalex.org/W4415791698","https://openalex.org/W4390105715","https://openalex.org/W4402887344","https://openalex.org/W7143321235","https://openalex.org/W7128048321","https://openalex.org/W4415790603","https://openalex.org/W7213997305"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4292242012","counts_by_year":[{"year":2026,"cited_by_count":39},{"year":2025,"cited_by_count":48},{"year":2024,"cited_by_count":54},{"year":2023,"cited_by_count":41},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2022-08-19T00:00:00"}
